BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18316782)

  • 1. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
    Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
    Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
    Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
    Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.
    Adler V; Bowne W; Kamran I; Michl J; Friedman FK; Chin E; Zenilman M; Pincus MR
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):491-8. PubMed ID: 18066549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
    Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
    Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
    Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
    Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
    Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells.
    Hsu YF; Lee TS; Lin SY; Hsu SP; Juan SH; Hsu YH; Zhong WB; Lee WS
    Mol Carcinog; 2007 Apr; 46(4):275-83. PubMed ID: 17295239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
    Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite role of Ras in tumor necrosis factor-alpha-induced cell cycle regulation: competition for Raf kinase.
    Park SJ; Kim YY; Lim JY; Seo GJ; Kim J; Park SI; Park BJ
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1140-7. PubMed ID: 11587542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
    Adler V; Pincus MR
    Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation.
    Chadee DN; Kyriakis JM
    Nat Cell Biol; 2004 Aug; 6(8):770-6. PubMed ID: 15258589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin modulates H-Ras mediated Raf-1 activation.
    Moretó J; Lladó A; Vidal-Quadras M; Calvo M; Pol A; Enrich C; Tebar F
    Cell Signal; 2008 Jun; 20(6):1092-103. PubMed ID: 18356021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
    Deng L; Boujdir M; Tremontano A; Pincus MR; El-Sherif N
    Ann Clin Lab Sci; 2009; 39(4):351-60. PubMed ID: 19880762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Raf/MAPK signaling in Xenopus oocyte extracts by Raf-1-specific peptides.
    Radziwill G; Steinhusen U; Aitken A; Moelling K
    Biochem Biophys Res Commun; 1996 Oct; 227(1):20-6. PubMed ID: 8858097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth.
    Kanovsky M; Michl J; Botzolaki G; Morin J; Kovac C; Chung DL; Chie L; Friedman FK; Pincus MR
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):202-8. PubMed ID: 12783204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.